TIMOTHY JAMIESON, MD, PhD
Timothy A. Jamieson, MD, PhD is a practicing radiation oncologist specializing in CyberKnife stereotactic radiosurgery and has been both an investor and active participant in several biotech start-ups.
He received his B.S. in Chemical Engineering from Penn State and M.D. and Ph.D. in Molecular Biology from the University of Virginia. Dr. Jamieson completed his Radiation Oncology residency at Duke University Medical Center where he won the American Radium Society's Young Oncologist Award for his research in tumor suppressor genes in head and neck cancer. He is medical director of the Cancer Care Center and the CyberKnife Center at Southeast Georgia Health System in Brunswick, GA, and is a Clinical Associate Professor with the Medical College of Georgia.
Dr. Jamieson is Chief Medical Officer for Palmetto Pharmaceuticals which has licensed an over-the-counter sustained release L-arginine drug used in cardiovascular disease prevention. Palmetto has extensive Intellectual Property in the use of statins in cardiovascular risk reduction and is currently involved in the licensing of this IP. The company is also developing a polymerized statin cardiac stent. Tim is also involved in FirstString research, a Charleston, SC-based biotech company specializing in wound repair and radiation injury.
Dr. Jamieson, a native of Boiling Springs, PA, resides in St. Simons Island, GA with his wife and 4 children ages 8 to 16.